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ABSTRACT 
Achillea eriophora (Asteraceae) is a medicinal plant commonly used in Iran. This study was performed to de-
termine the cardiovascular effects of hydroethanolic extract of A. eriophora (HEAE) and the underlying mecha-
nisms in anaesthetized rats. The acute effects of intravenous (i.v.) administration of different doses of HEAE (40, 
50, 60, 80 mg/kg), and its probable interaction with cholinergic and nitrergic systems were investigated in the 
presence of ACh and NOS blocker (L-NAME) as well as ethanol (HEAE solvent in sham group). Intravenous 
administration of different doses of HEAE induced hypotension. HEAE (60 mg/kg) significantly reduced mean 
arterial blood pressure (MAP), systolic arterial blood pressure (SBP) and diastolic arterial blood pressure (DBP) 
compared to control rats that treated with ethanol only, but no change in heart rate (HR) was seen in both groups. 
The results showed significant decrease in MAP, SBP, DBP and increase of HR in the presence of HEAE plus 
ACh (10 µg/kg) compared to when ACh was injected alone. Finally i.v. administration of HEAE, significantly 
reduced MAP and DBP in L-NAME (5 mg/kg) treated animals, while bradycardic responses to L-NAME were 
not significantly changed by HEAE. It can be concluded that Achillea eriophora induced hypotensive effect via 
lowering total peripheral resistance and cardiac output that may be synergist with cholinergic and independent of 
nitrergic system.  
 
Keywords: Achillea eriophora, hypotension, cholinergic system, nitrergic system 
 
 
 
 
INTRODUCTION 
Achillea eriophora DC. is an endemic 
species of Achillea genus in Iran. This plant 
is growing mainly in the southern provinces 
of Iran at an altitude of 700-3000 m 
(Weyerstahl et al., 1997). In Iran, it is popu-
larly known as “Bumadaran-e Shiraz” or 
“Sarzardu” and commonly used in traditional 
medicine for treatment of gastrointestinal 
disorders (Zargari, 1968). A. eriophora and 
related species are also used in traditional 
Persian medicine against various liver dis-
eases, dysmenorrhea, inflammation, fever 
and cardiovascular disorders (Zargari, 1968; 
1984). The genus Achillea L. belongs to 
Asteraceae, the largest family of vascular 
plants. Several species of Achillea have been 
used in folk medicine as anti-inflammatory, 
antispasmodic, diaphoretic and diuretic 
agents and for treatment of hemorrhagic side 
effects, pneumonia, rheumatic pain, and 
wounds since past centuries all over the 
world (Karamenderes and Apaydin, 2003;  
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Si et al., 2006; Yaeesh et al., 2006; De Souza 
et al., 2013). 
Among different species of the genus, A. 
millefolium L. have been tested in numerous 
experimental studies (reviewed in Nemeth 
and Bernath, 2008). In the previous studies, 
cardiovascular effects of this species such as 
hypotensive effect (DeSouza et al., 2011) 
and vasoprotective activity (Dall’Acqua et 
al., 2011) have been reported. Other species, 
A. wilhelmsii C. Koch is one of the wide 
spread species of Achillea in Iran (Kazemi 
and Rostami, 2015). It is shown that this 
plant has antioxidant and antimicrobial 
(Kazemi and Rostami, 2015), immunomodu-
latory (Sharififar et al., 2009) and antimyco-
bacterial (Tosun et al., 2004) activity. Fur-
theremore, it has been studied for its preven-
tive role in hepatotoxicity (Dadkhah et al., 
2014), inhibitory effect on gastric acid out-
put (Niazmand et al., 2010), antihypertensive 
and antihyperlipidemic effects (Asgary et al., 
2000). 
Phytochemical investigations of Achillea 
species revealed the presence of various bio-
active constituents. In the previous studies, 
the flavonoids, terpenoids, lignans, aminoac-
id derivatives, fatty acids and alkamids have 
been identified in Achillea species (reviewed 
in Si et al., 2006). Despite the folkloric use, 
there are a few reports dealing with the 
chemical composition of A. eriophora and its 
biological activities (e.g. Weyerstahl et al., 
1997; Ghasemi et al., 2008). Ghasemi et al. 
(2008) reported thirty-two chemical compo-
nents from A. eriophora essential oil, such as 
1,8 cineole, linalool, α-terpineole, and 
geranylformate. Considering the previous 
studies (e.g. Asgary et al., 2000; Dall’Acqua 
et al., 2011; De Souza et al., 2011) about 
cardiovascular effects of different species of 
Achillea genus and no scientific and direct 
data of cardiovascular effects of the species 
A. eriophora, the present study was done. It 
was supposed to determine more clear and 
complementary information about cardio-
vascular effects of hydroethanolic extract ob-
tained from leaves and flowers of A. 
eriophora.  
 
Chemical compounds studied in this article 
Ethanol (PubChem CID: 702); Urethane 
(PubChem CID: 5641); Heparin Sodium 
(PubChem CID: 22833565); Acetylcholine 
Chloride (PubChem CID: 6060); L-NAME 
(PubChem CID: 39836) 
 
MATERIALS AND METHODS 
Male wistar rats (220-250 g) were used 
in all experiments and housed at 22 ± 2 ºC 
under 12-hour light/12-hour dark cycle with 
free access to food and water. The protocols 
and procedures were approved by the Shiraz 
University Ethics Committee. 
 
Preparation of the extract 
Material of Achillea eriophora was col-
lected in June 2013 from Shiraz mountain, 
Fars province of Iran at 1600 m altitude 
above sea level ( N 29º 38΄ 52 – E 52º 31΄ 2). 
The plant was identified by A.R. Khosravi 
from Herbarium of Shiraz University (HSU). 
The voucher (no. 25049) were prepared and 
deposited in the HSU. Dried and powdered 
leaves and flowers of A. eriophora were ex-
tracted with 70 % ethanol. The hydroeth-
anolic extract was concentrated using rotary 
evaporator. The concentrated extract was 
freez–dried and the powder (yield 16.36 % 
w/w of dried plant material) was freshly dis-
solved in ethanol (70 %) before administra-
tion. 
 
Surgical preparations 
Adult male wistar rats were anaesthetized 
by intraperitoneal injection of urethane 
(1.2 g/kg). The animals were allowed to 
breath spontaneously through a tracheosto-
my. The left femoral vein and artery were 
exposed and cannulated with a heparinized 
polyethylene catheter (PE-50). The vein can-
nula was used for i.v. injection of the drugs, 
extract and extract solvent (ethanol 70 %), 
while the arterial cannula filled with hepa-
rinized saline and connected to a pressure 
transducer (MLT844), which was connected 
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to a powerlab (ADInstruments Company, 
Australia) for arterial blood pressure and 
heart rate recording. Immediately after ve-
nous cannulation, the rats were injected with 
heparin (30 IU), to prevent blood clotting. In 
order to stabilization of the blood pressure 
after the surgical process, an interval of 
60 min was held before any recording. Dur-
ing experiment, rectal temperature was kept 
close to 37˚C and 5 % dextrose in normal sa-
line was i.v. injected (3 ml/h). 
 
Experimental protocol  
Four series of experiments were per-
formed as follows. 
Series 1 
In the first series of experiments, differ-
ent doses of HEAE (40, 50, 60, 80 mg/kg) 
were i.v. administrated after the stabilization 
of blood pressure and HR. Each doses of 
HEAE was evaluated in four animals. The 
HEAE (60 mg/kg), defined as effective dose 
that produced immediate and long-lasting 
changes in MAP compared to the baseline 
values (Figure 1). 
Series 2 
In the second series, blood pressure and 
HR were recorded in a period of 30 min, 
then HEAE (60 mg/kg, i.v.) or equivalent 
volume of its solvent (ethanol 70 %, i.v.) 
were injected to rats (n = 5 for each treat-
ment) and arterial blood pressure (MAP, 
SBP, DBP) and HR were continuously moni-
tored for a period of 30 min. 
Series 3 
This series of experiments was per-
formed to assess the interaction of HEAE 
and its solvent (ethanol 70 %) with choliner-
gic system by the following procedure: first 
group served as experimental group in which 
distilled water, ACh, HEAE+ACh were in-
jected respectively (n = 5). The second group 
served as sham operated group in which dis-
tilled water, ACh, ethanol+ACh were inject-
ed respectively (n = 5). In both groups, after 
the blood pressure stabilization, distilled wa-
ter (as ACh solvent) was injected and cardi-
ovascular parameters such as HR, MAP, etc. 
were recorded for 10 min, then ACh (10 
µg/kg, i.v.) was injected and its effects on 
above parameters were recorded. Cardiovas-
cular parameters were allowed to return to 
baseline levels. In experimental group, in the 
last stage, HEAE (60 mg/kg) was injected 
and after the onset of the hypotension (after 
the fifth min), the rats received ACh and 
consequently, the parameters were recorded. 
In sham operated group, in the last stage, 
ethanol (equivalent volume of HEAE) was 
injected and after the fifth min, the animals 
received ACh and their cardiovascular pa-
rameters were recorded. 
Series 4 
This series of experiments was per-
formed to determine the interaction of HEAE 
and its solvent (ethanol 70 %) with nitrergic 
system by the following procedure: the first 
group as experimental group, in which dis-
tilled water (as L-NAME solvent), L-NAME 
(5mg/kg), HEAE (60 mg/kg) were injected 
respectively (n = 5). The second group as 
sham operated group, in which distilled wa-
ter, L-NAME (5mg/kg), ethanol (equivalent 
volume of HEAE) were injected respectively 
(n = 5).  
In the whole above series, the cardiovas-
cular parameters were recorded at the same 
times for sham and experimental rats. Ace-
tylcholine Chloride (Sigma-Aldrich Co., St. 
Louis, MO, USA) and L-NAME (Sigma-
Aldrich Co., St. Louis, MO, USA) were dis-
solved in distilled water and freshly prepared 
before any experiment. All drugs, extract and 
solvent were injected similarly to sham oper-
ated and experimental groups. 
 
Calculation and statistical analysis 
The data are expressed as the mean val-
ue ± standard error of the mean (S.E.M). 
Significant difference between groups was 
determined with Student’s t-test, and differ-
ence between stages of one group was de-
termined with repeated measure or paired 
sample t-test using SPSS software (version 
21.0). In all analysis, a p value < 0.05 consid-
ered as statistically significant. 
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RESULTS 
Effects of different doses of hydroethanolic 
extract of A. eriophora (HEAE) on mean 
arterial blood pressure (MAP). 
After the stabilization of blood pressure, 
i.v. administration of different doses of 
HEAE (40, 50, 60, 80 mg/kg) in different 
rats decreased MAP values (Figure 1). This 
effect became significant and long-lasting at 
the dose of 60 mg/kg, compared with the 
HEAE preinjection MAP values. This dose 
is close to the maximum immediate hypoten-
sive effect and this effect lasted about 60 min 
after treatment. 
 
Figure 1: Effects of intravenous injection of dif-
ferent doses of HEAE on the mean arterial blood 
pressure (MAP) of anaesthetized rats. The 
treatment started at min zero. Data are means ± 
S.E.M. of four animals 
 
Effects of HEAE and its solvent (ethanol 
70 %) on arterial blood pressure and HR 
The HEAE (60 mg/kg) decreased blood 
pressure (MAP, SBP, DBP), but baseline 
values of blood pressure, prior to and after 
i.v. administration of ethanol (as HEAE sol-
vent) were not significantly different (Figure 
2A, B). Neither HEAE nor ethanol altered 
HR during the observation period after treat-
ment (Figure 2C, D). During the base stage 
before HEAE administration, the recorded 
MAP was constant ranging from 99 to 103 
mm Hg in different periods of time (mins 1-
25, n = 5). After administration of HEAE (60 
mg/kg, i.v.), the MAP decreased to 
91.8 ± 3.4 mm Hg in mins 1-5, to 96.1 ± 1.9 
mm Hg in mins 5-10, to 93.1 ± 3.2 mm Hg 
in mins 10-15, to 89.8 ± 0.6 mm Hg in mins 
15-20, and to 87.4 ± 1.7 in mins 20-25 
(n = 5). 
 
 
 
 
Figure 2: Effects of HEAE (60 mg/kg, i.v.) and its 
solvent (ethanol 70 %, i.v.) on arterial blood 
pressure and HR in anaesthetized rats. Effects of 
HEAE on blood pressure (A) and HR (C).Effects 
of solvent (equivalent volume of the HEAE) on 
blood pressure (B) and HR (D). Each value 
shows mean ± S.E.M. (n = 5 for each) and statis-
tical analyses were performed by means of 
paired – sample t– test. ***p < 0.001, **p < 0.01, 
*p < 0.05 significantly different compared to 
same times in base stage. 
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Effects of HEAE and its solvent (ethanol 
70 %) on arterial blood pressure and HR 
responses to ACh 
In sham operated and experimental ani-
mals, the mean values of basal and control 
drug stage (i.v. treatment with distilled water 
as ACh solvent) MAP and HR recorded were 
not significantly different (Figure 3, A: 
MAP, and B: HR). 
 
(A) 
 
(B) 
 
Figure 3: Alteration of MAP: curve A and HR: 
curve B in anaesthetized rats in base stage and 
after i.v. administration of distilled water in sham 
operated and experimental groups for cholinergic 
system. The “B” in X axis refers to the base 
stage that rats no treated, and “W” refers to the 
control drug stage, treated with distilled water as 
ACh solvent. The difference between same 
stages and same times in two groups were de-
termined by means of unpaired t- test.  
 
In both sham operated and experimental 
groups, i.v. injection of ACh decreased 
MAP, SBP, DBP and HR in anaesthetized 
rats (Figure 4). In sham operated group, i.v. 
injection of ACh decreased MAP, SBP and 
DBP in rats that were pretreated with etha-
nol, but effects were similar to the stage that 
ACh injected alone (Figure 4B). In experi-
mental rats, ACh decreased MAP, SBP and 
DBP after administration of HEAE 
(60 mg/kg) and reduction of blood pressure 
was greater than the stage that ACh injected 
alone (Figure 4A). Heart rate in the presence 
of ethanol and ACh was similar with ACh 
alone (Figure 4D), however HR increased in 
the presence of HEAE and ACh (Figure 4C). 
Distilled water transitorily significant de-
creased HR in the first minutes in sham op-
erated animals which progressively returned 
back to the basal value in about 2-3 min 
(Figure 4D). 
 
Effects of HEAE and its solvent (ethanol 
70 %) on arterial blood pressure and HR 
responses to L-NAME 
To identify the mechanisms involved in 
the HEAE–induced hypotension, the role of 
the endothelial signaling pathways were dis-
sected. Because the NO-cGMP signalling is 
important in the regulation of endothelium–
dependent vasorelaxation (Grange et al., 
2001; Queen and Ferro, 2006), the effects of 
inhibition of endothelial NO – synthase 
(eNOS) activity were examined. In sham op-
erated and experimental animals, the mean 
values of baseline and control drug stage 
(i.v. treatment with distilled water as L-
NAME solvent) MAP and HR recorded were 
similar and have not significantly difference 
(Figure 5, top: MAP, bottom HR). As shown 
in Figure 6, i.v. administration of L-NAME 
(5 mg/kg), an inhibitor of eNOS, increased 
blood pressure (MAP, SBP, DBP) and de-
creased HR in sham operated and experi-
mental groups. Data showed that i.v. admin-
istration of HEAE and ethanol decreased 
MAP in rats that pretreated with L-NAME 
(Figure 6A and B), but the decrease in MAP 
produced by HEAE (in experimental group) 
was significantly greater than solvent (in 
sham operated group). In experimental ani-
mals, the administration of L-NAME 
(5mg/kg, i.v.) to anaesthetized rats increased 
the MAP from 86.2 ± 5.8 mm Hg (n = 5) to a 
leveling point in 120.7 ± 7.1 mm Hg (n = 5). 
Administration of HEAE (60 mg/kg, i.v.) af-
ter the blood pressure levelling, caused a 
significant and long-lasting reduction in 
MAP values (Figure 6A). 
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Figure 4: Hydroethanolic extract of A. eriophora (HEAE) and its solvent (ethanol 70 %) effects over 
arterial blood pressure and heart rate (HR) in anaesthetized rats in the presence of ACh (10 µg/kg). 
Change in blood pressure (A) and HR (C) with HEAE (60 mg/kg, i.v.) and ACh. Change in blood pres-
sure (B) and HR (D) with solvent (equivalent volume of HEAE, i.v.) and ACh. The “B” refers to the 
base stage that rats no treated, and “W” refers to the control drug stage, treated with distilled water as 
ACh solvent. The difference between same times in different stages were determined by means of re-
peated measure.a p < 0.05 significantly different compared to B. bp < 0.05 significantly different com-
pared to W; cp < 0.05 significantly different compared to ACh. 
 
(A) 
 
(B) 
Figure 5: Change in MAP: curve A and HR: curve B in anaesthetized rats in baseline and after i.v. 
administration of distilled water in sham operated and experimental groups for nitrergic system. The 
“B” refers to the baseline that rats no treated, and “W” refers to the control drug stage, treated with dis-
tilled water as L-NAME solvent. The difference between same stages and same times in two groups 
were determined by means of unpaired t- test.  
 
 
Maximum hypotensive effects were ob-
served within the 1-15 min after HEAE ad-
ministration (compared with the same times 
in L-NAME treatment), while ethanol hypo-
tensive effects in sham operated animals 
lasted shorter than in those observed in ex-
perimental rats. On the other hand, as shown 
in Figure 6C and 6D, HR of both groups was 
not altered significantly by HEAE or etha-
nol. Injection of ethanol, after L-NAME in 
the first minutes, increased HR, but this ef-
fect was not statistically significant (Figure 
6D). It is important to note that reduction in 
arterial blood pressure by HEAE after L-
NAME is mainly due to reduction in diastol-
ic pressure (Figure 6A). 
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Figure 6: Hydroethanolic extract of A. eriophora (HEAE) and its solvent (ethanol 70 %) effects over 
arterial blood pressure and heart rate (HR) in anaesthetized rats after intravenous (i.v.) administration 
of L-NAME (5 mg/kg). Change in blood pressure (A) and HR (C) with HEAE (60 mg/kg, i.v.). Change 
in blood pressure (B) and HR (D) with solvent (equivalent volume of HEAE, i.v.). The “B” refers to the 
base stage that rats no treated, and “W” refers to the control drug stage, treated with distilled water as 
L-NAME solvent. The difference between same times in different stages were determined by means of 
repeated measure.b p < 0.05 significantly different compared to W; c p < 0.05 significantly different 
compared to L-NAME. 
 
DISCUSSION 
The present study, using an invivo ap-
proach, shows for the first time that intrave-
nous (i.v.) treatment of anaesthetized rats 
with extract obtained from leaves and flow-
ers of A. eriophora lowers blood pressure. It 
has been reported that other Achillea species 
such as A. millefolium and A. wilhelmsii have 
beneficial effects on the cardiovascular sys-
tem (Asgary et al., 2000; Dall ҆ Acqua et al., 
2011; De Souza et al., 2011). Nevertheless, 
the cardiovascular effects of A. eriophora 
have not ever been demonstrated. Interest-
ingly, this study showed that i.v. administra-
tion of hydroethanolic extract of A. eriopho-
ra (HEAE) reduces the MAP of normal rats. 
According to our result, i.v. administration 
of 60 mg/kg of HEAE produced an intense 
and long-lasting hypotensive effect, without 
significant change in HR, but answer to this 
question that HEAE will be introduced as 
antihypertensive agent, further studies are 
required. Since hypertension is a chronic 
condition, so using medicinal plants for 
long-term use may be more beneficial (De 
Souza et al., 2011; Xiong et al., 2014). 
There are a few studies dealing with the 
chemical composition of A. eriophora and its 
biological activity. The previous studies 
showed that 1,8-cineole, linalool, α-
terpineole and geranylformate are the main 
components of the essential oil of A. 
eriophora (Ghasemi et al., 2008). Some in-
vestigators (e.g. Dokhani et al., 2005; De 
Souza et al., 2011) have reported that poly-
phenolic compounds are present in different 
species of Achillea such as A. eriophora.  
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Therefore, the hypotensive effects of 
HEAE can be attributed to a number of pol-
yphenolic compounds such as flavonoids as 
hypotensive, vasorelaxant and antihyperten-
sive agent (e.g. Ajay et al., 2003; Jiang et al., 
2005; Morello et al., 2006; Ajay et al., 2007; 
Cho et al., 2007; Magos et al., 2008; Dong et 
al., 2009; De Souza et al., 2011). 
In the present study, also an attempt was 
made to examine the role of cholinergic and 
nitrergic systems in the HEAE-induced hy-
potension. Result showed that treatment of 
animals with extract+ACh exhibited a signif-
icant decrease in MAP and tachycardia. The 
maximum hypotensive effect in the presence 
of extract +ACh was greater than ACh alone. 
These result suggest that blood pressure low-
ering effects of the extract is synergist with 
cholinergic system. It is important to note 
that the reduction of MAP in the presence of 
extract+ACh could initiated baroreceptor re-
flex that induced tachycardia (Lahlou et al., 
2002). 
In this study, the i.v. administration of L-
NAME as NO synthase inhibitor to normal 
rats increased the arterial blood pressure 
(SBP, DBP, MAP) and decreased HR that is 
consistent with previous studies (Hu et al., 
1997; Shin et al., 2014). Injection of HEAE 
(60 mg/kg, i.v.) after L-NAME, caused a 
significant and persistent reduction in MAP 
and DBP with no alteration of HR. This hy-
potensive effect was more prolonged in L-
NAME+HEAE treated animals than sham 
operated animals. These results indicate that 
the nitrergic system does not seem to play a 
significant role in the hypotensive effect of 
the extract. It should be remembered that in 
sham operated group, injection of ethanol as 
extract solvent after L-NAME in the first 
minutes induced a negligible and non-
significant increase of HR. This effect is in 
agreement with previous study which 
demonstrated that ethanol, inhibits the brad-
ycardic responses to NO synthase inhibitor 
(Wang and Pang, 1993). 
Since no changes in the HR were found 
in rats treated concomitantly with L-NAME 
and extract, it seems that the lowering of 
blood pressure may be due to reduction of 
total peripheral resistance. This hypothesis is 
supported by our result in which i.v. admin-
istration of extract significantly decreased 
DBP in L-NAME treated animals. It was 
proposed that lowering DBP induced by ex-
tract administration accompanied with tach-
ycardia, but in contrast no change of HR was 
seen, so it can be said that extract may di-
rectly affect the heart. 
The result of present study showed that 
HEAE has dual attenuate effects on blood 
pressure: via lowering total peripheral re-
sistance and cardiac output, that may be syn-
ergist to cholinergic system and independent 
of nitrergic system. However, further studies 
will be required to elucidate the real mecha-
nisms of this extract-induced hypotensive ef-
fect. 
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